NCT00000332View on ClinicalTrials.gov

High Dose Nimodipine Treatment Adjunct - 1

PHASE2CompletedINTERVENTIONAL
0
Timeline

Start Date

May 31, 1998

Primary Completion Date

January 31, 2000

Study Completion Date

April 30, 2000

Conditions
Cocaine-Related Disorders
Interventions
DRUG

Nimodipine

Trial Locations (1)

20422

Washington DC VA, Washington D.C.

All Listed Sponsors
collaborator

Washington D.C. Veterans Affairs Medical Center

FED

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00000332 - High Dose Nimodipine Treatment Adjunct - 1 | Biotech Hunter | Biotech Hunter